Whitehawk Therapeutics (WHWK) Cash from Investing Activities Growth (1y) (2017 - 2026)
Whitehawk Therapeutics (WHWK) Cash from Investing Activities Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Whitehawk Therapeutics |
288.03 Mn |
164.98 Mn |
- |
-83.18% |
| Date | Value |
|---|
| Mar 31, 2026 |
-83.18% |
| Dec 31, 2025 |
28.27% |
| Sep 30, 2025 |
-1,901.91% |
| Jun 30, 2025 |
-707.22% |
| Mar 31, 2025 |
994.25% |
| Dec 31, 2024 |
259.91% |
| Sep 30, 2024 |
-59.86% |
| Jun 30, 2024 |
-107.06% |
| Mar 31, 2024 |
-35.36% |
| Dec 31, 2023 |
104.32% |
| Sep 30, 2023 |
126.26% |
| Jun 30, 2023 |
21,079.67% |
| Mar 31, 2023 |
71,095.65% |
| Dec 31, 2022 |
-183,332.61% |
| Sep 30, 2022 |
-290.26% |
| Sep 30, 2021 |
371,507.65% |
| Sep 30, 2020 |
-59.47% |
| Dec 31, 2019 |
100.01% |
| Sep 30, 2019 |
79.50% |
| Mar 31, 2019 |
-1,233.05% |
